Zobrazeno 1 - 10
of 329
pro vyhledávání: '"Pico de Coaña Y"'
Autor:
del Pilar Sánchez Millas, Ma
Publikováno v:
Iberoamericana (2001-), 2015 Mar 01. 15(57), 241-244.
Externí odkaz:
https://www.jstor.org/stable/24369367
Autor:
Van Laethem JL; Erasme Hospital, Hopital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: jean-luc.vanlaethem@hubruxelles.be., Borbath I; Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert, Belgium., Prenen H; Department of Medical Oncology, University Hospital Antwerp, Edegem, Belgium., Geboes KP; Department of Gastroenterology, Division of Digestive Oncology, Ghent University Hospital, Ghent, Belgium., Lambert A; Institut de Cancerologie de Lorraine, Vandoeuvre les Nancy, France., Mitry E; Medical Oncology Department, Institut Paoli-Calmettes, Marseille, France., Cassier PA; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Blanc JF; Hôpital Haut-Lévêque, CHU de Bordeaux, Service Hépato-Gastroentérologie et Oncologie Digestive, Bordeaux, France., Pilla L; Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, Paris, France., Batlle JF; Department of Medical Oncology, La Paz University Hospital, IdiPAZ, UAM, CIBERONC, Madrid, Spain., Garrote MR; Hospital Ramón y Cajal, Madrid, Spain., Pazo-Cid RA; Hospital Universitario, Miguel Servet, Zaragoza, Spain., Gallego I; Virgen del Rocío University Hospital, Sevilla, Spain., Smith KE; Alligator Bioscience, Lund, Sweden., Ellmark P; Department of Immunotechnology, Lund University, Lund, Sweden; Alligator Bioscience, Lund, Sweden., Pico de Coaña Y; Alligator Bioscience, Lund, Sweden., Ambarkhane SV; Alligator Bioscience, Lund, Sweden., Macarulla T; Vall d'Hebrón University Hospital, Barcelona, Spain.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Jul; Vol. 25 (7), pp. 853-864. Date of Electronic Publication: 2024 Jun 01.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Poorebrahim M; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. mansour.poorebrahim@dkfz-heidelberg.de.; Targeted Tumor Vaccines Group, Clinical Cooperation Unit Applied Tumor Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany. mansour.poorebrahim@dkfz-heidelberg.de., Melief J; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Pico de Coaña Y; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., L Wickström S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Cid-Arregui A; Targeted Tumor Vaccines Group, Clinical Cooperation Unit Applied Tumor Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany., Kiessling R; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. rolf.kiessling@ki.se.
Publikováno v:
Oncogene [Oncogene] 2021 Jan; Vol. 40 (2), pp. 421-435. Date of Electronic Publication: 2021 Jan 14.
Autor:
Rad Pour S; Department of Medicine, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Stockholm, Sweden soudabeh.radp@yahoo.com Jesper.tegner@kaust.edu.sa., Pico de Coaña Y; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Demorentin XM; Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain., Melief J; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Thimma M; Biological and Environmental Sciences and Engineering Division (BESE), KingAbdullah University of Science and Technology KAUST, Thuwal, 23955, Saudi Arabia., Wolodarski M; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Karolinska University Hospital, Stockholm, Sweden., Gomez-Cabrero D; Department of Medicine, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Stockholm, Sweden.; Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.; Biological and Environmental Sciences and Engineering Division (BESE), KingAbdullah University of Science and Technology KAUST, Thuwal, 23955, Saudi Arabia., Hansson J; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Karolinska University Hospital, Stockholm, Sweden., Kiessling R; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Karolinska University Hospital, Stockholm, Sweden., Tegner J; Department of Medicine, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Stockholm, Sweden soudabeh.radp@yahoo.com Jesper.tegner@kaust.edu.sa.; Biological and Environmental Sciences and Engineering Division (BESE), KingAbdullah University of Science and Technology KAUST, Thuwal, 23955, Saudi Arabia.; Computer, Electrical, and Mathematical Sciences and Engineering Division (CEMSE), KingAbdullah University of Science and Technology KAUST, Thuwal, 23955, Saudi Arabia.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 May; Vol. 9 (5).
Autor:
Zhou, Ping1 (AUTHOR), Liu, Bing2 (AUTHOR), Shen, Ning1 (AUTHOR), Fan, Xiaoting1 (AUTHOR), Lu, Shangwei2 (AUTHOR), Kong, Zhijuan2 (AUTHOR), Gao, Ying2 (AUTHOR), Lv, Zhimei1,2 (AUTHOR) lvzhimei_sd@163.com, Wang, Rong1,2 (AUTHOR) sd_wangrong@163.com
Publikováno v:
Renal Failure. Dec2024, Vol. 46 Issue 2, p1-10. 10p.
Autor:
Pico de Coaña Y; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Wolodarski M; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Theme Cancer, Patient Area Head and Neck, Lung, and Skin, Karolinska University Hospital Solna, Stockholm, Sweden., van der Haar Àvila I; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Nakajima T; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan., Rentouli S; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Lundqvist A; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Masucci G; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Theme Cancer, Patient Area Head and Neck, Lung, and Skin, Karolinska University Hospital Solna, Stockholm, Sweden., Hansson J; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Theme Cancer, Patient Area Head and Neck, Lung, and Skin, Karolinska University Hospital Solna, Stockholm, Sweden., Kiessling R; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Theme Cancer, Patient Area Head and Neck, Lung, and Skin, Karolinska University Hospital Solna, Stockholm, Sweden.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2020 Aug 28; Vol. 9 (1), pp. 1786888. Date of Electronic Publication: 2020 Aug 28.
Autor:
Babačić H; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden., Lehtiö J; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden., Pico de Coaña Y; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden., Pernemalm M; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden maria.pernemalm@ki.se., Eriksson H; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.; Theme Cancer/Department of Oncology/Skin Cancer Centre, Karolinska University Hospital, Stockholm, Sweden.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 May; Vol. 8 (1).
Autor:
Melief J; Department of Oncology-Pathology, Karolinska Institute, Visionsgatan 4, 171 64 Solna, Stockholm, Sweden. jeroen.melief@ki.se., Pico de Coaña Y; Department of Oncology-Pathology, Karolinska Institute, Visionsgatan 4, 171 64 Solna, Stockholm, Sweden., Maas R; Department of Oncology-Pathology, Karolinska Institute, Visionsgatan 4, 171 64 Solna, Stockholm, Sweden.; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland., Fennemann FL; Department of Oncology-Pathology, Karolinska Institute, Visionsgatan 4, 171 64 Solna, Stockholm, Sweden.; Department of Tumor Immunology, Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Wolodarski M; Department of Oncology-Pathology, Karolinska Institute, Visionsgatan 4, 171 64 Solna, Stockholm, Sweden.; Karolinska University Hospital Solna, Stockholm, Sweden., Hansson J; Department of Oncology-Pathology, Karolinska Institute, Visionsgatan 4, 171 64 Solna, Stockholm, Sweden., Kiessling R; Department of Oncology-Pathology, Karolinska Institute, Visionsgatan 4, 171 64 Solna, Stockholm, Sweden.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Apr; Vol. 69 (4), pp. 513-522. Date of Electronic Publication: 2020 Jan 17.
Autor:
Taherifard, Erfan1 (AUTHOR) erfantaherifard@gmail.com, Tran, Krystal1 (AUTHOR) kbt19@pitt.edu, Saeed, Ali2 (AUTHOR) asaeedmd@gmail.com, Yasin, Jehad Amer1 (AUTHOR) jehadamerjehadyasin@gmail.com, Saeed, Anwaar1,3 (AUTHOR) saeeda3@upmc.edu
Publikováno v:
Diagnostics (2075-4418). Sep2024, Vol. 14 Issue 18, p2054. 19p.